Royalty Pharma plc
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
7/10
|
17.6 | 57.09 | -69.17% | 96.52 | -81.76% |
| P/S |
|
6.68 | 33.5 | -80.06% |
|
|
| P/BV |
|
1.63 | 4.61 | -64.7% |
|
|
| P/FCF |
|
4.76 | 39.66 | -88.01% |
|
|
| Ev/Ebitda |
|
14.8 | -19.46 | -176.06% |
|
|
| Ev/S |
|
9.75 | 22.56 | -56.77% |
|
|
| Ev/FCF |
|
7.97 | 45.47 | -82.46% |
|
|
| E/P |
|
0.0652 | 0.0172 | 278.03% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
10/10
|
57.07 | -14.42 | -495.73% | 59.66 | -4.34% |
| ROE |
|
17.39 | 9.01 | 92.98% |
|
|
| ROA |
|
6.93 | 0.0151 | 45641.21% |
|
|
| ROIC |
|
6.21 | 7.63 | -18.66% |
|
|
| ROS |
|
37.94 | -26.5 | -243.14% |
|
|
| ROCE |
|
14.74 | 13.75 | 7.18% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
1/10
|
4.75 | -3.73 | -227.36% | 5.71 | -16.83% |
| Nеt Debt/Ebitda |
|
4.38 | -3.19 | -237.14% |
|
|
| Debt/Ratio |
|
0.3745 | 0.1777 | 110.73% |
|
|
| Debt/Equity |
|
2.41 | 1.57 | 53.1% |
|
|
| Debt/Net Income |
|
7.14 | 0.8429 | 747.33% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
7.3/10
|
2.92 | 0.5467 | 434.15% | 1.92 | +51.91% |
| Number of years of dividend growth |
|
7 | 0.7368 | 850% | ||
| DSI |
|
1 | 0.2387 | 318.9% |
|
|
| Average dividend growth |
|
20.73 | 1.55 | 1241.85% |
|
|
| Average percentage for 5 years |
|
1.92 | 0.4967 | 286.98% |
|
|
| Average percentage for payments |
|
130.96 | 43.73 | 199.48% |
|
|
| Difference from average difference in sector |
|
2.37 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
1/10
|
6.69 | 73.67 | -90.92% | ||
| Growth impulse Ebitda in 5 years |
|
-31.35 | 15.28 | -305.17% | ||
| Growth impulse Net Income in 5 years |
|
-11.9 | -33.08 | -64.03% | ||
| Growth impulse FCF in 5 years |
|
36.07 | -6.99 | -616.02% | ||
| Growth impulse EPS in 5 years |
|
9.79 | -59.11 | -116.56% |
IP Score
5.37/10
